Trimeric HIV-1-Env Structures Define Glycan Shields from Clades A, B and G
Stewart-Jones, G.B.E., Soto, C., Lemmin, T., Chuang, G.Y., Druz, A., Kong, R., Thomas, P.V., Wagh, K., Zhou, T., Behrens, A.J., Bylund, T., Choi, C.W., Davison, J.R., Georgiev, I.S., Joyce, M.G., Kwon, Y.D., Pancera, M., Taft, J., Yang, Y., Zhang, B., Shivatare, S.S., Shivatare, V.S., Lee, C.C.D., Wu, C.Y., Bewley, C.A., Burton, D.R., Koff, W.C., Connors, M., Crispin, M., Korber, B.T., Wong, C.H., Mascola, J.R., Kwong, P.D.(2016) Cell 165: 813
- PubMed: 27114034 
- DOI: 10.1016/j.cell.2016.04.010
- Primary Citation of Related Structures:  
5FYJ, 5FYK, 5FYL - PubMed Abstract: 
The HIV-1-envelope (Env) trimer is covered by a glycan shield of ∼90 N-linked oligosaccharides, which comprises roughly half its mass and is a key component of HIV evasion from humoral immunity. To understand how antibodies can overcome the barriers imposed by the glycan shield, we crystallized fully glycosylated Env trimers from clades A, B, and G, visualizing the shield at 3 ...